Vir Biotechnology Inc (NASDAQ:VIR)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - VIR

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - VIR

  • Market Cap$6.199bn
  • SymbolNASDAQ:VIR
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS92764N1028

Company Profile

Vir Biotechnology Inc is a clinical-stage immunology company focused on treating and preventing infectious diseases. It has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA, through internal development, collaborations, and acquisitions. The company's pipeline consists of product candidates targeting hepatitis B virus, or HBV, influenza A, human immunodeficiency virus, or HIV, and tuberculosis, or TB.

Latest VIR news

Currently there for this company. Visit our news hub for other news .